abstract |
Disclosed herein are compositions and methods for treating spinal muscular atrophy (SMA). In certain embodiments, compounds are provided that increase full-length survival of motor neuron (SMN) protein production by the SMN2 gene. [Selection] FIGS. 1A, 1B and 1C |